15Indexed trials
mesh condition
Cerebral Hemorrhage
Intelligence
Cerebral Hemorrhage intelligence: 15 indexed trials, 7 recruiting studies, 14 sponsors across 18 countries.
7Recruiting
14Sponsors
18Countries
Leading sponsors
Massachusetts General Hospital22 recruiting
MD Stem Cells11 recruiting
Melbourne Health11 recruiting
OSF Healthcare System10 recruiting
Penumbra Inc.10 recruiting
Region Skane11 recruiting
Rong Hu, MD10 recruiting
Tang Zhouping11 recruiting
Universitat Autonoma de Barcelona10 recruiting
University Hospital, Basel, Switzerland11 recruiting
University of Erlangen-Nürnberg Medical School10 recruiting
University of Minnesota10 recruiting
Geographic activity
United States7trials
Canada2trials
China2trials
Australia2trials
Germany2trials
Denmark1trials
Hong Kong1trials
Iceland1trials
Italy1trials
Japan1trials
Malaysia1trials
South Korea1trials
Leading interventions
Best medical treatment (BMT)1trials
Cattle Encephalon Glycoside and Ignotin1trials
Device: Phase II MTD in Phase I1trials
Device: Phase II lower than the MTD in Phase I1trials
Device: Phase Ⅰ Dose Level 11trials
Device: Phase Ⅰ Dose Level 21trials
Device: Phase Ⅰ Dose Level 31trials
Do-not-resuscitate (DNR) or withdrawal of care1trials
Early intensive blood pressure lowering1trials
Early minimally invasive image guided endoscopic hematoma evacuation1trials
Hyperglycemia treatment1trials
Artemis Neuro Evacuation Device1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.